10 Questions You Need to Ask Before Investing in Marijuana Stocks

合法化席卷整个美国,大麻股票崛起令投资者兴奋

2018-12-17 13:47:02 PROFIT

本文共2728个字,阅读需7分钟

Weed is a commonly used substance in North America, yet it remains taboo in most communities. Until very recently, this “sin substance” has been kept in the shadows. But the rise of marijuana stocks is changing everything. Legalization is sweeping across the nation. Many investors are excited (rightfully so) about this opportunity to multiply their money. Those who invest in marijuana stocks could easily make 400% or 500% within one year. Many already have. But before you rush off to invest in every marijuana stock you can get your hands on, remember to ask yourself the essential questions about investing in marijuana stocks. This is a young industry with plenty of room to grow; estimates peg the potential size of marijuana sales at $50.0 billion per year by 2026. (Source: “Marijuana industry could be worth $50 billion annually by 2026,” MarketWatch, April 22, 2017.) This opportunity is clear as day, but many analysts are constrained by politics. While that mood is changing, there’s still a long way to go before total marijuana legalization becomes politically feasible in many countries across the world. So, before you empty your savings account, ask yourself the following questions. Investing in marijuana stock is not a “sure thing” or “100% guarantee”—those are a conman’s words. There is risk involved in any investment, and people should know that. Marijuana stocks are no different than any other asset class in this regard. No risk, no reward. In fact, there is arguably more volatility in marijuana stocks due to the age of the industry. This means that wild swings are more likely—it helps spur growth but can also increase risk. And then there’s a lot of “political risk” surrounding the industry. While the new Farm Bill 2018 legalized hemp and may lead to cannabidiol (CBD) legalization in the near future, the federal government in the U.S. still needs to grapple with these questions. Cannabis is, after all, still a Schedule 1 drug under the Controlled Substances Act in the United States. This means that it is technically illegal at the federal level. So how are marijuana companies flourishing in states like Colorado and Oregon? Shouldn’t the FBI or the Drug Enforcement Administration (DEA) shut them down? Actually, no. After several states legalized recreational weed, the Department of Justice (DoJ) issued a new directive on drug enforcement. It basically green-lit (pun intended) the commercial sale of marijuana, albeit under tight restrictions. The states took this policy and ran with it. But if the DoJ starts singing a different tune, marijuana companies could be at serious risk. That risk was heavily mitigated by the replacement of Jeff Sessions, a known drug crusader, as Attorney General. On the federal level, it looks like things will be returning to the status quo…for now. But the future is leaning toward legalization; over 30 states have legalized medicinal marijuana and 10 states in addition to Washington D.C. have legalized pot for recreational use. As an emerging growth sector, marijuana stocks are not advisable for conservative investors. However, “safe” is a relative term. If you are an adrenaline-junkie who’s been skydiving for years, then one more jump feels pretty safe. It’s just one out of a hundred, right? But for someone like me, jumping out of a plane seems borderline insane. It feels much less than safe. This relativism of safety applies to the stock market perfectly. High-risk investors know that many of their bets will go bust, but they only need one big winner to make up for it. That’s their mentality, so emerging growth stocks are “safe” to them. But if you cringe at a 0.10% drawdown in your portfolio, then maybe steer clear of these stocks. Investing in marijuana stocks can be done through public exchanges and over-the-counter (OTC) markets. There is a growing presence of marijuana stocks on the Nasdaq and New York Stock Exchange (NYSE), but many are still OTC and available on Canadian exchanges. More specifically, there are different corners of the weed market. For example, there are medical marijuana companies, marijuana producer stocks, and marijuana services stocks. Medical marijuana stocks are involved in the development, patenting, and distribution of cannabinoid-related drugs. These drugs are based off chemical properties found in cannabis, and are used in treating everything from cancer patients to chronic pain. Marijuana producer stocks actually grow and manage “the plant.” They are the ones that will sell directly to consumers, which is what most of us think when we hear the words “marijuana stocks.” They will profit from the pot boom. Marijuana services stocks lend support to the categories above. Whether by providing real estate services or social media services, many of these companies are growing rapidly. Ironically, their success is due to the federal ban on marijuana. Because other firms are scared to do business with weed dealers, these services stocks were able to carve out a niche. For more information on these types of stocks, click here. Taxation is the downside of a federal ban on marijuana. IRS Code 280E allows Uncle Sam to tax a marijuana company’s sales minus the “cost of goods sold.” In other words, the government is marking gross profit, not net profit, as the total pie of taxable income. To the best of my knowledge, this doesn’t happen to any other business in the U.S.! That means everything from marketing costs to research to debt payments is not taken into account. The government is squeezing them for every possible dollar. At present, many banks are reluctant to do business with marijuana companies. Financial institutions usually operate across the entire country and are therefore regulated at the federal level. You can hardly blame them. But those who do take on marijuana-related clients must deliver Suspicious Activity Reports (SARs) for every transaction. That can be expensive. My guess is that some ambitious firm will fill this gap. After all, marijuana stocks are seeping into the zeitgeist, they are becoming a visible asset class, and it won’t be long until someone realizes they can make a lot of money having cannabis clients. In the past, President Trump has spoken negatively about marijuana use and marijuana legalization. But his administration seems to have drawn several lines in the sand, including one between medical and recreational uses. The other is between state and federal authority. “I think it’s up to the states,” said Trump in an interview with a Denver television station back in August 2016. “I’m a states person. I think it should be up to the states, absolutely.” (Source: “Brandon Rittiman’s Trump interview transcript,” 9NEWS, August 3, 2016.) This perspective is historically in line with the Republican party. The GOP has traditionally preferred that states govern themselves as much as possible, so that local values overrule the bureaucrats in Washington D.C. As it happens, this decision would be good for investors. If marijuana stocks simply grow on a state-by-state basis, they will soon become a regular feature of American commerce. Seeing dispensaries might seem as normal as seeing liquor stores, which would reduce the stigma and restrictions placed on the weed industry. Canada is a fast-growing market for marijuana stocks now that marijuana has seen full-scale legalization in the country. Additionally, investing in Canadian marijuana stocks helps hedge against U.S. political risk. Germany has also begun to show promise as marijuana companies are flocking to one of the largest markets in the world, hoping to set up foundations as medical marijuana expands—and potentially recreational pot, too. The marijuana industry is in what I would term the adolescent phase of its growth. While the extreme surges of the sector’s very early days are likely gone for the next little while, we can still expect to see 100% or even 200% growth as the industry continues to expand. In fact, this is the safest the industry has ever been. While gains may not reach 500% again, there’s a good chance that marijuana stocks will double or triple in value when countries like the U.S. legalize pot. In the meantime, much of the danger that was present earlier in the market has since disappeared. Here are five of the biggest pot stocks by valuation, as of December 2018: However, any of these stocks could double or even triple at any time, so this list could flip on its head within six months. Once again, it’s important to remember that marijuana is an emerging growth industry. Nothing is locked in place for long. It depends. I can’t stress this point enough, but only you know how much risk is enough. To be sure, there are stocks that have surged by more than 500%. Some investors have already walked away from marijuana stocks as millionaires, but this path isn’t for everyone.
Wed 在北美是一种常用的物质,但在大多数社区仍然是禁忌。直到最近,这种“罪恶物质”一直被隐藏在阴影中。但大麻库存的增加正在改变一切。合法化正在席卷全国。 许多投资者对这个让他们的钱倍增的机会感到兴奋(这是正确的)。那些投资大麻股票的人在一年内可以轻松赚到400%或500%。许多人已经有了。 但在你匆忙投资每一只大麻股票之前,记得问问自己有关投资大麻股票的基本问题。 这是一个年轻的行业,有很大的增长空间;估计到2026年大麻销售的潜在规模为每年500亿美元。(来源:“到2026年,大麻产业每年可能价值500亿美元,” MarketWatch ,2017年4月22日)。 这种机会一天天都很明显,但许多分析师受到政治的制约。尽管这种情绪正在改变,但在全球许多国家,大麻合法化在政治上变得可行之前,还有很长的路要走。 所以,在你把储蓄账户空出来之前,先问问自己以下的问题。 投资大麻股票不是一件“确定的事情”或“100%的保证”——这是一个 conman 的话。任何投资都有风险,人们应该知道。在这方面,大麻股票与任何其他资产类别没有什么不同。没有风险,没有回报。 事实上,由于大麻行业的年龄,大麻股票的波动性可能更大。这意味着剧烈波动的可能性更大——它有助于刺激增长,但也可能增加风险。 然后围绕该行业存在很多“政治风险”。 尽管2018年新的《农业法案》将大麻合法化,并可能在不久的将来导致大麻( CBD )合法化,但美国联邦政府仍需要解决这些问题。 毕竟,大麻仍然是美国《受控物质法案》规定的附表1药物。这意味着它在技术上在联邦一级是非法的。 那么,大麻公司如何在科罗拉多州和俄勒冈州等州蓬勃发展?联邦调查局或缉毒局是否应该关闭他们?事实上,不。 在几个州将娱乐杂草合法化后,美国司法部( DoJ )发布了一项新的毒品执法指令。它基本上是绿灯(双关语意)的商业出售大麻,尽管受到严格的限制。各州采取了这一政策并实行了这一政策。 但如果美国司法部开始唱另一首歌,大麻公司可能面临严重风险。 这一风险大大降低了替代杰夫塞申斯,一个著名的毒品十字军,作为总检察长。在联邦一级,现在看来情况将恢复到现状。 但未来将倾向于合法化;30多个州已经将药用大麻合法化,除了华盛顿之外,还有10个州已经将大麻合法化,用于娱乐用途。 作为新兴的增长领域,大麻股票不适合保守的投资者。 然而,“安全”是一个相对术语。如果你是个肾上腺素依赖型的人,多年来一直在跳伞,那么再跳一跳就会感觉很安全。这只是百万分之一,对吧?但对于像我这样的人来说,跳出飞机似乎有点疯狂。感觉不太安全。 这种安全相对主义完全适用于股票市场。高风险投资者知道他们的许多赌注将会破产,但他们只需要一个大赢家来弥补。这是他们的心态,因此新兴成长型股票对他们来说是“安全的”。 但如果你对投资组合中0.10%的跌幅感到畏缩不前,那么你可能会避开这些股票。 投资大麻股票可以通过公共交易所和场外市场进行。在纳斯达克和纽约证券交易所( NYSE )有越来越多的大麻股票,但许多仍在场外交易,并在加拿大的交易所上市。 更具体地说,杂草市场有不同的角落。 例如,有医用大麻公司、大麻生产者股票和大麻服务股票。 医用大麻库存涉及大麻相关药物的开发、专利申请和分销。这些药物基于大麻中的化学特性,用于治疗从癌症患者到慢性疼痛的各种疾病。 大麻生产者的库存实际上是增长和管理“植物”。它们将直接出售给消费者,这是我们大多数人在听到“大麻股票”这个词时的想法。他们将从繁荣的锅中获利. 大麻服务类股票支持上述类别。不管是提供房地产服务还是社交媒体服务,这些公司中的许多都在快速增长。具有讽刺意味的是,他们的成功是由于联邦禁止大麻。因为其他公司害怕与野草经销商做生意,这些服务的股票能够开辟一个利基市场。 有关此类股票的详细信息,请单击此处。 税收是联邦禁止大麻的不利因素。IRS 代码280E 允许山姆大叔对一家大麻公司的销售额减去“售出商品的成本”征税。换句话说,政府将毛利润,而不是净利润作为应税收入的总馅饼。 据我所知,这并不发生在美国的任何其他行业!这意味着从营销成本到研究,再到债务支付,一切都没有考虑在内。政府正在为每一美元挤压他们。 目前,许多银行不愿与大麻公司做生意。金融机构通常在全国范围内运作,因此在联邦一级受到监管。你很难责怪他们。 但是,那些与大麻相关的客户必须为每笔交易提交可疑活动报告。这可能是昂贵的。 我猜想一些雄心勃勃的公司会填补这个空缺.毕竟,大麻股票正渗透到这个时代,它们正成为一种明显的资产类别,只有在有人意识到拥有大麻客户的时候,它们才能赚到很多钱。 过去,特朗普总统曾对大麻使用和大麻合法化发表过负面言论。但他的政府似乎在沙地画了几条线,包括医疗和娱乐用途之间的线。另一种是在州和联邦政府之间。 “我认为这取决于各州,”特朗普在2016年8月接受丹佛电视台采访时表示。“我是州人。我认为应该完全由各州来决定。”(来源:“ Brandon Ritiman 的特朗普采访记录,”9NEWS ,2016年8月3日) 这种观点在历史上与共和党是一致的。传统上,共和党倾向于让各州尽可能多地管理自己,这样当地的价值观就会推翻华盛顿特区的官僚们。实际上,这一决定对投资者是有利的。 如果大麻只是在各州的基础上增长,它们很快就会成为美国商业的常规特征。看药房似乎和看酒类商店一样正常,这将减少对杂草行业的污名和限制。 加拿大是大麻市场快速增长的国家,大麻已经在全国得到了全面的合法化。此外,投资加拿大大麻股票有助于规避美国政治风险。 随着大麻公司纷纷涌入全球最大的市场之一,德国也开始展现出希望,希望在医用大麻扩张之际建立基金会,同时也有可能提供娱乐大麻。 大麻产业正处于我所说的青少年阶段。 虽然该行业极早的几天可能会出现极端的激增,但随着该行业继续扩张,我们仍有望看到100%甚至200%的增长。 事实上,这是该行业有史以来最安全的一次。 虽然大麻的涨幅可能不会再达到500%,但当像美国这样的国家将大麻合法化时,大麻股票的价值很有可能翻一番或翻两番。与此同时,市场早期出现的许多危险已经消失。 以下为截至2018年12月按估值计算最大的五只罐装股票: 然而,这些股票中的任何一只在任何时候都可能翻两倍甚至三倍,因此这份名单可能在6个月内倒下。再次,重要的是要记住,大麻是一个新兴的增长行业。没有什么东西被长期锁定。 它取决于.我不能强调这一点,但只有你知道多少风险是足够的。可以肯定的是,有些股票上涨了500%以上。一些投资者已经离开了大麻股票,成为百万富翁,但这条道路并不适合每个人。

以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

阅读原文